Literature DB >> 31654986

Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn's disease patients with higher levels of perceived stress.

Laura M Mackner1, Emmanuel Hatzakis2, Jacob M Allen3, Ronald H Davies3, Sandra C Kim4, Ross M Maltz5, Michael T Bailey6.   

Abstract

Stress is associated with increased Crohn's Disease (CD) activity. This pilot study tested whether pediatric patients with CD reporting higher levels of perceived stress exhibited differences in the fecal microbiome and metabolome. The perceived stress scale (PSS) questionnaire was administered within 2 days of collecting a stool sample for microbiome (using 16S rRNA gene sequencing) and metabolome (using NMR metabolomics) analyses. Higher levels of perceived stress were correlated with increased disease activity on the short Pediatric Crohn's Disease Activity Index (sPCDAI). Patients with High PSS scores vs. Low PSS scores based on a median split had significantly lower relative abundances of Firmicutes and Anaerostipes, as well as higher relative abundances of Parabacteroides. Fecal alanine and nicotinate were also significantly different in patients with High vs. Low PSS Scores. This pilot study suggests that the fecal microbiome and metabolome differs in pediatric patients with CD and high perceived stress.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Metabolome; Microbiome; Pediatric Crohn’s disease; Stress

Mesh:

Substances:

Year:  2019        PMID: 31654986      PMCID: PMC6956257          DOI: 10.1016/j.psyneuen.2019.104469

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  47 in total

1.  Everyday stress and Crohn's disease activity: a time series analysis of 20 single cases.

Authors:  H C Traue; P Kosarz
Journal:  Int J Behav Med       Date:  1999

2.  Short pediatric Crohn's disease activity index for quality improvement and observational research.

Authors:  Michael D Kappelman; Wallace V Crandall; Richard B Colletti; Anthony Goudie; Ian H Leibowitz; Lynn Duffy; David E Milov; Sandra C Kim; Bess T Schoen; Ashish S Patel; John Grunow; Evette Larry; Gerry Fairbrother; Peter Margolis
Journal:  Inflamm Bowel Dis       Date:  2010-09-01       Impact factor: 5.325

3.  Social Stress Affects Colonic Inflammation, the Gut Microbiome, and Short-chain Fatty Acid Levels and Receptors.

Authors:  Ross M Maltz; Jeremy Keirsey; Sandra C Kim; Amy R Mackos; Raad Z Gharaibeh; Cathy C Moore; Jinyu Xu; Arpad Somogyi; Michael T Bailey
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-04       Impact factor: 2.839

4.  Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity.

Authors:  Houssam E Mardini; Kevin E Kip; John W Wilson
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

5.  Human metabolic phenotype diversity and its association with diet and blood pressure.

Authors:  Elaine Holmes; Ruey Leng Loo; Jeremiah Stamler; Magda Bictash; Ivan K S Yap; Queenie Chan; Tim Ebbels; Maria De Iorio; Ian J Brown; Kirill A Veselkov; Martha L Daviglus; Hugo Kesteloot; Hirotsugu Ueshima; Liancheng Zhao; Jeremy K Nicholson; Paul Elliott
Journal:  Nature       Date:  2008-04-20       Impact factor: 49.962

6.  Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product.

Authors:  Sylvia H Duncan; Petra Louis; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

7.  Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice.

Authors:  Roman Dziarski; Shin Yong Park; Des Raj Kashyap; Scot E Dowd; Dipika Gupta
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

8.  Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals.

Authors:  Jacob Tveiten Bjerrum; Yulan Wang; Fuhua Hao; Mehmet Coskun; Christian Ludwig; Ulrich Günther; Ole Haagen Nielsen
Journal:  Metabolomics       Date:  2014-06-01       Impact factor: 4.290

9.  Dietary Oligosaccharides Attenuate Stress-Induced Disruptions in Immune Reactivity and Microbial B-Vitamin Metabolism.

Authors:  Jacob M Allen; Robert M Jaggers; Lindsey M Solden; Brett R Loman; Ronald H Davies; Amy R Mackos; Christopher A Ladaika; Brian M Berg; Maciej Chichlowski; Michael T Bailey
Journal:  Front Immunol       Date:  2019-07-29       Impact factor: 7.561

10.  Prolonged restraint stressor exposure in outbred CD-1 mice impacts microbiota, colonic inflammation, and short chain fatty acids.

Authors:  Ross M Maltz; Jeremy Keirsey; Sandra C Kim; Amy R Mackos; Raad Z Gharaibeh; Cathy C Moore; Jinyu Xu; Vasudevan Bakthavatchalu; Arpad Somogyi; Michael T Bailey
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

View more
  4 in total

Review 1.  Metabolomics facilitate the personalized management in inflammatory bowel disease.

Authors:  Rirong Chen; Jieqi Zheng; Li Li; Chao Li; Kang Chao; Zhirong Zeng; Minhu Chen; Shenghong Zhang
Journal:  Therap Adv Gastroenterol       Date:  2021-12-21       Impact factor: 4.409

2.  Psychological stress disrupts intestinal epithelial cell function and mucosal integrity through microbe and host-directed processes.

Authors:  Jacob M Allen; Amy R Mackos; Robert M Jaggers; Patricia C Brewster; Mikaela Webb; Chia-Hao Lin; Chris Ladaika; Ronald Davies; Peter White; Brett R Loman; Michael T Bailey
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 3.  Stress gets into the belly: Early life stress and the gut microbiome.

Authors:  Liisa Hantsoo; Babette S Zemel
Journal:  Behav Brain Res       Date:  2021-07-16       Impact factor: 3.352

4.  Impact of a Model Used to Simulate Chronic Socio-Environmental Stressors Encountered during Spaceflight on Murine Intestinal Microbiota.

Authors:  Corentine Alauzet; Lisiane Cunat; Maxime Wack; Laurence Lanfumey; Christine Legrand-Frossi; Alain Lozniewski; Nelly Agrinier; Catherine Cailliez-Grimal; Jean-Pol Frippiat
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.